DIVISLAB's weekly return of 1.37% was a moderate performance, with a relatively low volatility of 12.53% compared to its peers. The stock outperformed SUNPHARMA and CIPLA, but underperformed DRREDDY. With a Sharpe Ratio of 0.43, the stock's return was decent considering the risk taken. The Max Drawdown of -0.23% indicates a relatively stable performance.

[Volatility: 12.53%]